Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Vienna Hypothermic Oxygenated Machine Perfusion Study
A clinical trial update from the Medical University of Vienna describes a study on hypothermic oxygenated machine perfusion for liver condit…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma
A clinical trial is evaluating serum glycomics as prognostic and diagnostic biomarkers for recurrence of hepatocellular carcinoma in liver t…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Paediatric Hepatic International Tumour Trial [Phase 3]
This is an update on a pediatric Phase 3 international trial evaluating treatments for liver tumors. The study is currently active but not r…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT
A completed clinical trial update evaluating plasma biomarkers to predict response and toxicity in hepatocellular carcinoma patients treated…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation
The trial update describes research and potential application of a new clinical diagnosis and treatment system for HBV-related hepatocellula…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer [Phase 2]
A Phase 2 clinical trial evaluating chidamide in combination with sintilimab and bevacizumab as first-line therapy for advanced hepatocellul…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation [Phase 1, Phase 2]
A clinical trial update announces a Phase 1/Phase 2 study of FOLFOX plus lenvatinib as adjuvant therapy for hepatocellular carcinoma after l…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy [NA]
This update describes a clinical trial evaluating transcutaneous electrical acupoint stimulation (TEAS) for chronic pain and survival in pat…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update for Cadonilimab in combination with Lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellul…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC. [Phase 4]
Phase 4 clinical trial comparing triple versus dual adjuvant therapy after liver resection in hepatocellular carcinoma is currently recruiti…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC [Phase 2]
A Phase 2 clinical trial evaluating the combination of sintilimab, bevacizumab, and selective internal radiation therapy (SIRT) for non-rese…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma [Phase 4]
A Phase 4 clinical trial evaluating precision adjuvant therapy after surgery for hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma
A clinical trial evaluating AKR1B10 as a biomarker to guide interventional therapy for hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis [Phase 2]
Phase II study evaluating moderate-dose hypofractionated radiotherapy combined with pembrolizumab for hepatocellular carcinoma with diffuse …
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma [NA]
A clinical trial sponsored by Taipei Veterans General Hospital in Taiwan is evaluating the use of ChatGPT to educate patients with early-sta…
-
CLINICAL_TRIALS research · 2022-11-30Clinical Trial Update: Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors [Phase 4]
Clinical trial update comparing propofol-based total intravenous anesthesia versus sevoflurane anesthesia for long-term outcomes after elect…
-
CLINICAL_TRIALS research · 2022-08-29Clinical Trial Update: Sintilimab Combined With Lenvatinib Versus HAIC for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial evaluating sintilimab plus lenvatinib versus HAIC as perioperative therapy for resectable hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2019-08-20Clinical Trial Update: Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma [Phase 4]
A Phase 4 clinical trial investigating mechanisms of sorafenib resistance in patients with advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2019-04-23Clinical Trial Update: Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization [Phase 2]
Phase 2 clinical trial investigating an integrated imaging strategy to phenotype progression of liver tumors during and after chemoembolizat…
-
CLINICAL_TRIALS research · 2019-02-21Clinical Trial Update: Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC
This entry reports an ongoing clinical trial evaluating chemoembolization using LifePearl polyethylene glycol drug-eluting microspheres load…
-
CLINICAL_TRIALS research · 2019-02-18Clinical Trial Update: Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer [Phase 4]
Clinical trial update for a Phase 4 study evaluating Cinobufacini combined with transarterial chemoembolization (TACE) in primary liver canc…
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection [Phase 2]
This entry describes a Phase 2 clinical trial evaluating the combination of Apatinib Mesylate and the PD-1 inhibitor camrelizumab (SHR-1210)…
-
CLINICAL_TRIALS research · 2019-01-28Clinical Trial Update: A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction [NA]
A clinical trial comparing side-by-side versus stent-in-stent techniques for malignant hilar biliary obstruction. The study lists cholangioc…
-
CLINICAL_TRIALS research · 2019-01-24Clinical Trial Update: Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery [NA]
Clinical trial update on using robotic endomicroscopy to better define resection strategies during hepatic surgery.
-
CLINICAL_TRIALS research · 2018-07-27Clinical Trial Update: Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer [Phase 1, Phase 2]
This update discusses a Phase 1/2 clinical trial evaluating the effectiveness and safety of ultrasound-guided percutaneous radiofrequency ab…